HCA Healthcare reports third-quarter revenue growth for HCA Healthcare stock

Published on 10/27/2026 at 16:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Adjusted earnings rose 3.7 percent to USD 7.22 in the third quarter of 2026. HCA Healthcare stock costs EUR 400.90 on October 27, 2026 during trading.

Third-quarter results and outlook

HCA Healthcare reported USD 19.849 billion in third-quarter 2026 revenue on October 27, 2026.
Adjusted diluted earnings per share rose 3.7 percent to USD 7.22 in the third quarter of 2026.
HCA Healthcare stock cost EUR 400.90 at Lang & Schwarz on October 27, 2026 at 4:12 p.m. CEST.
The company declared a USD 0.78 quarterly dividend payable on December 29, 2026.

HCA Healthcare, US40412C1018, Illustration mit AI erstellt.

HCA Healthcare (ISIN US40412C1018) reported third-quarter 2026 revenue of USD 19.849 billion on October 27, 2026, up 3.6 percent from USD 19.161 billion in the prior-year quarter, according to HCA Healthcare. HCA Healthcare was trading at EUR 400.90 at Lang & Schwarz on October 27, 2026 at 4:12 p.m. CEST.

Revenue rose as earnings mixed

Net income attributable to HCA Healthcare declined 3.9 percent to USD 1.579 billion in the third quarter, while diluted earnings per share increased 4.5 percent to USD 7.27. Adjusted diluted earnings per share rose 3.7 percent to USD 7.22, and adjusted EBITDA increased 1.2 percent to USD 3.918 billion, according to the company release dated October 27, 2026.

The operating picture was uneven. Same-facility admissions increased 2.7 percent and emergency room visits rose 5.1 percent, but same-facility inpatient surgeries declined 1.4 percent and outpatient surgeries fell 3.7 percent during the third quarter.

What did the payer shift cost?

The payer mix shift caused by higher uninsured volume reduced pretax income by approximately USD 400 million in the third quarter, Becker's Hospital Review reported on October 27, 2026. That pressure helps explain why revenue growth did not translate into higher GAAP net income.

Debt and cash flow set the frame

HCA reported USD 4.461 billion in operating cash flow for the third quarter and USD 50.493 billion in total debt as of September 30, 2026. The company repurchased 7.230 million shares for USD 2.970 billion during the quarter and had USD 4.240 billion remaining under its authorization.

Management said full-year 2026 results should land in the upper half of its existing ranges. Those ranges call for revenue of USD 77.000 billion to USD 79.500 billion and net income of USD 6.300 billion to USD 6.700 billion. The company also declared a USD 0.78 quarterly dividend payable on December 29, 2026 to holders of record on December 15, 2026.

Healthcare peers show a wider spread

HCA Healthcare's NYSE quote was USD 443.27 on October 27, 2026 at 11:23 a.m. EDT, with a price-to-earnings ratio of 14.62 and a market capitalization of USD 96.0 billion. Tenet Healthcare traded at USD 262.52 with a price-to-earnings ratio of 10.12 and a market capitalization of USD 21.1 billion, while Universal Health Services traded at USD 176.00 with a price-to-earnings ratio of 7.21 and a market capitalization of USD 10.4 billion at the same date.

Dates and investor markers

The next concrete shareholder date is December 15, 2026, the record date for the declared dividend. Payment follows on December 29, 2026, while the third-quarter conference call was scheduled for October 27, 2026 at 9:00 a.m. Central Time.

Stock price and operating balance

HCA combines 3.6 percent quarterly revenue growth with a 3.9 percent decline in net income and a USD 400 million payer-mix burden. The next market assessment will center on whether admissions growth and cost controls can offset that pressure.

The further course of trading is shown by the continuously updated real-time quote of HCA Healthcare stock.